Side-by-side financials for CSTL and GH. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CSTL | GH |
|---|---|---|
| Market cap | - | $17.36 B |
| US-listed rank | - | #680 |
| Revenue (latest FY) | $344.23M | $982.02M |
| Net income (latest FY) | -$24.16M | -$416.30M |
| Net margin | -7.0% | -42.4% |
| SEC filings | 828 | 1,131 |
In their latest fiscal years, CASTLE BIOSCIENCES INC reported $344.23M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: CASTLE BIOSCIENCES INC and Guardant Health, Inc., or browse the full rankings.